| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |